Article

Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation

2021-09-22

Abstract excerpt

<h4>Background</h4> Short-chain fatty acids (SCFAs) produced by the gut microbiota have beneficial anti-inflammatory and gut homeostasis effects and prevent type 1 diabetes (T1D) in mice. Reduced SCFA production indicates a loss of beneficial bacteria, commonly associated with chronic autoimmune and inflammatory diseases, including T1D and type 2 diabetes. Here we addressed whether a metabolite-based dietary suppl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0d807977-b245-5d3b-bf30-fdfa5b7c008a
DOI: 10.1101/2021.09.15.21263059

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulationDOI 10.1101/2021.09.15.21263059Read

Evaluating the Effect of Prebiotics on the Gut Microbiome Profile and β-cell Function in Youth with Newly-Diagnosed Type 1 Diabetes: Protocol of a Randomized Controlled TrialSemantic proximity Read

Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose HomeostasisSemantic proximity Read

Gut Microbiome: Profound Implications for Diet and DiseaseSemantic proximity Read

Gut-Microbiota-Derived Metabolites and Probiotic Strategies in Colorectal Cancer: Implications for Disease Modulation and Precision TherapySemantic proximity Read

Microbiota-accessible carbohydrates (MACs) as novel gut microbiome modulators in noncommunicable diseasesSemantic proximity Read

Dietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseasesSemantic proximity Read

Impact of dietary resistant starch type 4 on human gut microbiota and immunometabolic functionsSemantic proximity Read

The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilitiesSemantic proximity Read

Modulating the Gut Microbiome in Obesity: Interventions and Clinical ImplicationsSemantic proximity Read

Unveiling roles of beneficial gut bacteria and optimal diets for healthSemantic proximity Read

Metabolic interplay of SCFA’s in the gut and oral microbiome: a link to health and diseaseSemantic proximity Read